High Rate of Mobilization for blaCTX-Ms by Barlow, Miriam et al.
We constructed a phylogenetic analysis of class A β-
lactamases and found that the blaCTX-Ms  have been mobi-
lized to plasmids ≈10 times more frequently than other class 
A  β-lactamases. We also found that the blaCTX-Ms are de-
scended from a common ancestor that was incorporated in 
ancient times into the chromosome of the ancestor of Kluy-
vera species through horizontal transfer. Considerable se-
quence divergence has occurred among the descendents 
of that ancestral gene sequence since that gene was insert-
ed. That divergence has mainly occurred in the presence of 
purifying selection, which indicates a slow rate of evolution 
for blaCTX-Ms in the pre–antimicrobial drug era.
A
ntimicrobial drug–sensitive bacteria become resistant 
to antimicrobial drugs through a variety of mecha-
nisms, such as chromosomal mutations that up-regulate 
the expression of antibiotic-resistance genes, DNA uptake 
through transformation, or the process of conjugation. The 
ability of plasmids to evolve independently of their hosts 
has allowed numerous resistance genes from diverse spe-
cies of bacteria to assemble within single plasmids and 
spread into a wide variety of organisms (1). The mobili-
zation of a chromosomal resistance gene to a plasmid is 
an important event because the mobilized gene is now ca-
pable of spreading widely throughout diverse species of 
bacteria and because the ﬁ  tness advantage that a plasmid 
confers generally increases as it acquires more resistance 
genes (1).
The class A β-lactamases have been the most fre-
quently encountered plasmidic resistance genes. Class 
A β-lactamases from the TEM group have occurred at a 
particularly high frequency; in many surveillance studies, 
they have been identiﬁ  ed as the resistance determinants 
most frequently encountered (2–9). The ﬁ  rst blaTEM allele, 
blaTEM-1, is a plasmidic allele that was ﬁ  rst isolated in 1963 
(10,11). Currently, ≈160 different plasmidic alleles encode 
unique TEM β-lactamase enzymes (www.lahey.org/Stud-
ies), and all are descended from a single plasmidic ances-
tor, blaTEM-1 (12). 
The SHVs are another group of class A β-lactamases 
that have been frequently observed in surveillance studies. 
As with the TEMs, numerous alleles encode unique SHV 
enzymes (≈105), and the SHVs are all descended from a 
single ancestor (13). The ﬁ  rst blaSHV allele was detected in 
1974 (10,14). Unlike blaTEMs, the blaSHVs are present in the 
chromosome of nearly all Klebsiella pneumoniae isolates 
belonging to the KP1 group. Evidence suggests that blaSHVs 
have been chromosomally located since the pre–antimicro-
bial drug era (15), and they may have been mobilized to 
plasmids up to 4 times, although the sequence divergence 
among them is insufﬁ  cient to clearly resolve the indepen-
dent mobilizations of the blaSHVs. 
The CTX-Ms are another group of class A β-lac-
tamases that are located on plasmids and that have been 
of particular clinical interest because they are rapidly 
spreading through clinical populations of bacteria. The ﬁ  rst 
plasmidic blaCTX-M observed in human-associated clinical 
populations was isolated in 1989 (16,17). Unlike the usual 
pattern of class A β-lactamase mobilizations in which the 
plasmidic alleles are all descended from a single common 
plasmidic ancestor, evidence shows that CTX-Ms have 
been mobilized numerous times from the chromosomes 
of Kluyvera (16,18–21). Because Kluyvera chromosomal 
genes have been found that exactly match the sequence of 
plasmidic CTX-Ms (18), many of the mobilizations have 
likely occurred recently. To investigate the mobilization 
of the blaCTX-Ms to plasmids, we generated a phylogenetic 
High Rate of Mobilization 
for blaCTX-Ms 
Miriam Barlow,* Rebecca A. Reik,† Stephen D. Jacobs,* Mónica Medina,* Matthew P. Meyer,* 
John E. McGowan, Jr.,† and Fred C. Tenover‡
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 3, March 2008  423 
*University of California, Merced, California, USA; †Emory Univer-
sity, Atlanta, Georgia, USA; and ‡Centers for Disease Control and 
Prevention, Atlanta, Georgia, USA RESEARCH
analysis of the CTX-Ms that included a representative sam-
pling of other class A β-lactamases.
Methods
BLAST Search
blaCTX-M and blaCTX-M homologue DNA sequences were 
identiﬁ  ed with a TBLASTN (www.ncbi.nlm.nih.gov/blast) 
(22,23) search of the nonredundant National Center for 
Biotechnology Information (NCBI) sequence database 
and the completed microbial genomes database by using 
characterized blaCTX-MS as query sequences (blaCTX-M1 and 
blaCTX-M2). The BLAST search of the completed microbial 
genomes identiﬁ   ed positive matches for organisms that 
contain blaCTX-M homologs. The BLAST search of com-
pleted genomes also showed which microbes have no close 
blaCTX-M homologue, and thus enabled horizontal transfer 
events to be identiﬁ  ed.
Alignment
The protein sequences of the blaCTX-Ms and their ho-
mologs were aligned with ClustalX 1.8 (24) by using the 
Gonet 250 similarity matrix with a gap-opening penalty 
of 35 and a gap-extension penalty of 0.75 for the pairwise 
alignment stage, and a gap-opening penalty of 15 and a gap 
extension penalty of 0.3 for the multiple alignment stage. 
The corresponding DNA coding sequences were aligned by 
introducing triplet gaps between codons corresponding to 
gaps in the aligned protein sequences with the CodonAlign 
program. (CodonAlign for Macintosh and for PC [Win-
dows] computers and source code that can be compiled for 
other platforms are available at no charge from http://sinau-
er.com/hall.)
Estimation of Positive Selection
Estimation of the nonsynonymous (dN) and synony-
mous (dS) substitution rates is an important means of un-
derstanding mechanisms of molecular evolution. A dN/dS 
ratio >1 is taken as evidence of positive selection, whereas 
a dN/dS ratio <1 is taken as evidence of purifying selection 
(25). The Codeml program of the PAML package (avail-
able from http://envgen.nox.ac.uk/bioinformatics/docs/co-
deml.html) (25) was used to estimate dN/dS ratios in the 
phylogenetic analysis shown in Figure 1. The values were 
calculated by using model 1 in the program, and default 
parameters were used for the execution of the program.
Phylogenetic Reconstruction
Phylogenies were constructed by the Bayesian method, 
as implemented by the program MrBayes (26) (available 
at no charge from www.mrbayes.net). The evolutionary 
model used was the General Time Reversible model (27). 
Because evolutionary rates are not homogeneous for every 
site in a gene, among-site variation in evolutionary rate was 
estimated separately for ﬁ  rst, second, and third positions of 
sites within codons. Four chains, with a “temperature” of 
0.2 for the heated chains, were run for each tree. Trees were 
sampled every 100 generations. A total of 10 million gen-
erations were run with a burn-in of 5,000 trees. The length 
of each burn-in was set at a value that exceeded twice the 
number of trees required for convergence upon a stable 
likelihood value. Because the consensus trees calculated by 
MrBayes do not include the posterior probabilities of the 
clades, each entire set of trees was imported into PAUP* 
(28) and the same trees used by MrBayes to calculate a 
consensus were used to calculate a 50% majority rule con-
sensus in PAUP* (28). The resulting tree shows the poste-
rior probabilities of the clades, i.e., the percentage of time 
that those taxa are included in the clade. The consensus 
trees calculated by MrBayes were imported into PAUP* 
for the purposes of displaying and printing the tree.
Results
Ancient Horizontal Transfer of blaCTX-M Ancestor
The NCBI genomes database (www.ncbi.nlm.nih.
gov:80/entrez/query.fcgi?db=genome) currently contains 
the completed genomic sequences of 139 eubacterial organ-
isms. Because Kluyvera are members of the Enterobacte-
riaceae group of the gamma subdivision of Proteobacteria, 
the genomes of other members of the gamma subdivision, 
and especially the chromosomes of Enterobacteriaceae, 
were of the greatest interest. BLAST searches of these mi-
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Figure 1. Phylogenetic analysis of blaCTX-Ms. This tree was calculated 
by Bayesian inference. Number of mutations occurring along 
each branch are given along the length of the branch. Black dots 
represent mobilizations. Boldface indicates chromosomal genes. 
CTX-M-14 and 3a exist as both unmobilized chromosomal genes 
and plasmid-borne CTX-M alleles.Mobilization of blaCTX-Ms
crobial genomes show that among the complete genomic 
sequences available for 9 species of Enterobacteriaceae 
(Escherichia coli, Salmonella typhimrium LT2, S. enterica, 
Shigella  ﬂ  exneri,  Photorhabdus luminescens, Buchnera 
aphidicola, Candidatus Blochmannia ﬂ  oridanus, Wiggles-
worthia glossinidia, and Yersinia pestis) none contain 
chromosomal homologs of the blaCTX-Ms that are detect-
able through sequence comparison. BLAST searches simi-
larly show that many non-Enterobacteriaceae members 
of the gamma subdivision of Proteobacteria, Shewanella 
oneidensis, Haemophilus ducreyi, H. inﬂ  uenzae, Pseudo-
monas aeruginosa, P. putida, P. syringae, Vibrio cholerae, 
V. parahemolyticus, V. vulniﬁ  cus, Xanthomonas axonopo-
dis, X. campestris, and Xylella fastidiosa, also do not con-
tain chromosomal homologs of the blaCTX-Ms. However, 
BLAST searches of the translated nonredundant nucleotide 
database revealed that Kluyvera species, Citrobacter sed-
lakii, and Klebsiella oxytoca contain close chromosomal 
homologs of the blaCTX-Ms.
These results show that the blaCTX-M homologs origi-
nally came into the chromosomes of K. oxytoca, Kluyverra 
species, and C. sedlakii by horizontal transfer because most 
species of gamma Proteobacteria do not contain blaCTX-M 
homologs. If blaCTX-M homologs were vertically transmit-
ted into the species that contain them, numerous deletions 
would be required to explain absence of those homologs 
in the majority of gamma Proteobacteria. However, only 
3 horizontal insertions are required to explain the pres-
ence of blaCTX-M homologs in the chromosomes of K. oxy-
toca, Citrobacter species. Because fewer insertions than 
deletions are required to explain these data, insertion of 
blaCTX-M homologs into the chromosomes of those bacteria 
that contain them is the most likely explanation for their 
current distribution.
Divergence of the blaCTX-Ms
The GenBank DNA and protein accession numbers of 
the sequences included in this analysis are shown in the 
online Appendix Table (available from www.cdc.gov/EID/
content/14/3/423-appT.htm), along with the organism in 
which the gene exists and whether the gene was located 
on a plasmid or a chromosome. The results of our phyloge-
netic analysis are presented in Figure 1. The groupings of 
blaCTX-Ms on our phylogenetic analysis agree with the den-
drogram published by Bonnet in a recent review (16); for 
purposes of clarity, we will use the same group names used 
in that review, as shown in Figure 1.
The phylogenetic analysis shows that the blaCTX-Ms 
represent a fairly divergent group of β-lactamase genes 
descended from a common ancestor. The genes encoding 
the CTX-M-1 and CTX-M-2 groups are separated by over 
400 mutations, which indicates considerable diversiﬁ  ca-
tion of the blaCTX-Ms. The average distance separating the 
blaCTX-Ms from their most recent common ancestor is 
226.2-nt ± 22.8-nt mutations, which indicates that the rates 
of evolution among the blaCTX-Ms have been similar.
Positive selection testing within the phylogenetic anal-
ysis shows that positive selection has occurred throughout 
the evolutionary history of the class A β-lactamases. More 
positive selection appears to exist at branches deep within 
the tree than along more recent branches. The branches dur-
ing which most of the divergence of the blaCTX-Ms occurred 
are characterized by purifying selection. The detection of 
purifying selection suggests a slow evolutionary rate and 
that the blaCTX-Ms diverged in ancient times. More recent 
evolution of the blaCTX-Ms likely can be characterized by in-
tense positive selection, but the branches at the tips are still 
too short to obtain reliable dN/dS ratios.
Mobilization of blaCTX-Ms to Plasmids
The blaCTX-Ms have been mobilized from the chromo-
somes of various Kluyvera species to plasmids at least 8 
times since they diverged from their most recent common 
ancestor as indicated in Figure 1. The alleles in the CTX-
M-2 group have been mobilized from the chromosome of 
Kluyvera ascorbata at least twice (29). The alleles in the 
CTX-M-9 group have been mobilized once from the chro-
mosome of Kluyvera georgiana (30). The alleles from the 
CTX-M-8 group were mobilized once from the chromo-
some of K. georgiana (20). The CTX-M-25 group has been 
mobilized once, although the species from which it origi-
nates has not yet been determined. The alleles in the CTX-
M-1 group have been mobilized at least 3 times (17,18,31), 
and one of those mobilizations has been from the chromo-
some of K. ascorbata. When compared with the blaTEMs, 
which have been mobilized once, and the blaSHVs, which 
have been reported to have been mobilized 2–4 times (32), 
the number of mobilization events that have occurred 
among the blaCTX-Ms is atypically high.
To compare the number of mobilizations that have oc-
curred in the CTX-M group with those that have occurred 
in the rest of the class A β-lactamases, we constructed a 
phylogenetic analysis of class A alleles that spans the 
breadth of this group and that contains representatives of 
all groups of class A alleles known to the authors (Figure 
2). Among all of the class A β-lactamases, including the 
blaCTX-Ms, only 22 mobilizations to plasmids were found. 
To quantitatively compare the numbers of times that CTX-
Ms have been mobilized to plasmids with the number of 
times that other class A β-lactamases have been mobilized 
to plasmids, the total number of mutations that have oc-
curred within the blaCTX-M clade were summed and divided 
by the number of mobilizations that have occurred in that 
region of the phylogenetic analysis. Among the blaCTX-Ms, 
the ratio of mobilizations to mutations is 1 mobilization per 
191 mutations. Among the remainder of the tree when the 
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blaCTX-M clade is excluded from the analysis, 14 mobiliza-
tions occur with the ratio of mobilizations to mutations be-
ing 1 mobilization per 2,471 mutations. When the complete 
phylogenetic analysis is considered, 1 mobilization occurs 
per 1,870 mutations. By that comparison, the mobilization 
of the blaCTX-M genes to plasmids has occurred at an un-
usually high rate. This result is unlikely to be an artifact 
of sampling bias or clinical interest because other class A 
β-lactamases have been intently studied for a longer period 
than the blaCTX-Ms. If any bias exists in the data, it would 
be the undersampling of blaCTX-M mobilizations relative to 
other class A β-lactamases.
Because nearly one half of the mobilizations that have 
occurred in the class A phylogenetic analysis have occurred 
among the blaCTX-Ms, it seemed reasonable to conclude that 
the circumstances associated with the mobilizations of the 
blaCTX-Ms may differ from the circumstances associated 
with the mobilizations of other class A β-lactamases. To 
rule out any effect that varying intensities of selection or 
varying evolutionary rates might have on mobilizations to 
plasmids, we divided the phylogenetic analysis into sev-
eral monophyletic groups for further analysis. Within the 
class A β-lactamase phylogenetic analysis (Figure 2) are 
several monophyletic clades that descended from a single 
ancestor (node A). Each of the monophyletic clades that 
descended from node A were considered separately during 
positive selection testing except for the monophyletic clade 
that contains the blaCTX-Ms; it was divided into 2 separate 
clades so that a clade containing only the blaCTX-Ms and their 
closest relatives could be considered. Monophyletic clades 
that diverged before the point represented at node A were 
also examined individually.
The dN/dS ratios were computed for each clade (Table), 
and a correlation coefﬁ  cient for mobilizations and dN/dS ra-
tios of 0.21 (p = 0.40) was calculated. The average distance 
of each clade from the root of the tree was also computed 
(Table), and the correlation coefﬁ  cient for mobilizations 
and average distance from the root is 0.21 (p = 0.41). The 
nonsigniﬁ  cant p values yielded by those results mean that 
the unusually high number of mobilizations among the 
blaCTX-Ms are probably not an artifact caused by positive se-
lection or evolutionary rate.
Most of the mobilizations of the blaCTX-Ms have occurred 
in recent years because genes that are identical (blaCTX-M3a 
[18] and blaCTX-M-18 [19]) or nearly identical to the ancestors 
of plasmidic clades (Figure 1) have been found in the chro-
mosomes of Kluyvera species, whereas many of the other 
plasmidic class A β-lactamases have been mobilized much 
longer, perhaps even since ancient times. In many cases, 
no chromosomal ancestor is identiﬁ  ed and the plasmidic 
resistance genes are not closely related to the chromosomal 
resistance genes of any identiﬁ  ed groups of bacteria.
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Figure 2. Phylogenetic analysis of class A β-lactamases calculated 
by Bayesian inference. Number of mutations occurring along each 
branch are represented visually by the lengths of the branches. 
dN/dS ratios for all branches except the tips are given along the 
lengths of the branches. Boldface indicates plasmidic genes. 
Black dots indicate mobilizations to plasmids. Numbered brackets 
indicate monophyletic divisions within the tree. dN, nonsynonymous 
substitution rate; dS, synonoymous substitution rate.




from root  dN/dS ratio*  Mobilizations 
1  3140.865  0.0935  5 
2  2534.35  0.4535  0 
3  2538.9  0.2446  0 
4  2819.37634  0.0929  9 
5  3139.5  0.0426  0 
6  2575.3  0.5024  0 
7  2975.7  0.1019  1 
8  2443.35  0.2618  0 
9  2532.075  0.1969  1 
10  3267.81  0.0338  0 
11  2429.7  0.0118  1 
12  2811.9  0.016  0 
13  2218.125  1.1595  0 
14  1747.2  0.9331  1 
15  873.6  0.2056  0 
16  518.7  0.1069  1 
17  559.65  0.1595  1 
18  778.05  0.2496  0 
*dN, nonsynonymous substitution rate; dS, synonoymous substitution rate. Mobilization of blaCTX-Ms
Discussion
Although the use of antimicrobial agents generally has 
enhanced the spread of antimicrobial drug resistance among 
bacteria by providing the selective pressure needed for the 
emergence of novel resistance determinants, selective pres-
sure alone does not explain the increasing frequency with 
which blaCTX-M alleles have been noted in bacterial popula-
tions in recent years (16,33). Although blaCTX-M alleles tend 
to be located on transmissible plasmids and transposable el-
ements, which clearly facilitate their dissemination, the re-
peated mobilization of the blaCTX-Ms from the chromosomes 
principally among Kluyera species is most intriguing. The 
mechanistic basis underlying this repeated mobilization to 
plasmids remains unknown. Whether the chromosomes of 
Kluyvera species have some unique aspect that enhances 
the mobilization of the blaCTX-M genes remains to be deter-
mined. Other factors, such as exposure of the isolates to 
speciﬁ  c antimicrobial agents or to environmental changes 
that facilitate the mobilization of blaCTX-Ms to plasmids also 
need to be investigated.
Two insertion elements are known to contribute to the 
mobilization of blaCTX-Ms. The ﬁ  rst, which is associated with 
the CTX-M-2 and CTX-M-9 groups, is ISCR1 (34) and the 
second, which is associated with the CTX-M-1, CTX-M-8, 
and CTX-M-25 groups is ISEcp1 (35). According to our 
phylogenetic analysis (Figure 1), 4 mobilizations can be 
attributed to each of these insertion type elements. Thus, 
both elements seem to promote equal frequencies of mo-
bilization of blaCTX-Ms. Notably, ISCR1 was also reported 
to be responsible for the mobilization of both blaVEB and 
blaPER alleles, but neither of these resistance determinants 
has been reported to have an unusually high rate of mobili-
zations from chromosomal locations to plasmids.
Another factor that may contribute to the rate of mobi-
lizations of the blaCTX-M resistance determinants is the fre-
quency of plasmids in bacterial populations. As the number 
of plasmids increases in microbial populations, so does the 
number of target replicons. A comparison of the percentage 
of bacterial strains that contained plasmids in the pre–anti-
microbial drug era (36) with the percentage of contempo-
rary strains that carry plasmids (37,38) indicates that the 
frequency of plasmid carriage has increased from 19% to 
58%–100%, depending on the species surveyed. Although 
the collection methods and resistance detection assays var-
ied in the studies used for this comparison (which may have 
introduced biases toward an increasing frequency of plas-
mids), few doubt that plasmid carriage is much more com-
mon among bacterial strains in the antimicrobial drug era 
(39,40). Unfortunately, speciﬁ  c information about plasmid 
carriage of Kluyvera species versus other Enterobacteria-
ceae is not available.
Regardless of the mechanism, the increased number 
of mobilizations of blaCTX-Ms from their chromosomal loca-
tions among relatively rare human pathogens to plasmids 
that circulate widely among several important human and 
animal pathogens (particularly among E. coli) is a serious 
public health concern. The results of our study indicate the 
potential for an increase in the rate of mobilization of a va-
riety of other resistance determinants to plasmids. Such an 
increase could result in more rapid mobilizations of novel 
resistance determinants and contribute to the accelerated 
spread of antimicrobial resistance determinants among a 
large spectrum of bacterial pathogens.
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